美股异动｜马西莫医疗跌超4.3% 苹果宣布更新Apple Watch血氧测量功能

Core Viewpoint - Masimo Corporation (MASI.US) experienced a decline of over 4.3%, trading at $149.14, following Apple's announcement of a new blood oxygen measurement feature for its Apple Watch models after receiving U.S. government approval [1] Company Impact - The introduction of the blood oxygen measurement feature on Apple Watch Series 9, Series 10, and Apple Watch Ultra 2 could pose a competitive threat to Masimo, which specializes in medical monitoring technologies [1] Market Reaction - The stock price drop of Masimo reflects investor concerns regarding the potential impact of Apple's new feature on the company's market position and revenue [1]